Ads
related to: herceptin, kadcyla- Side Effects & Tips
Understand Potential Side Effects
When Taking KADCYLA® As A Treatment
- How KADCYLA® May Work
View The Safety Of KADCYLA® And How
The Treatment Is Thought To Work.
- Taking KADCYLA®
Learn How KADCYLA® Is Given & Ask
Your Doctor If It Is Right For You.
- HERConnection Support
Discover A Free Support Program For
Patients Currently Taking KADCYLA®.
- Financial Information
View Financial Resources That May
Help You Pay For Treatment.
- Questions For Your Doctor
Find Important Prescribing And
Safety Questions To Ask Here.
- Side Effects & Tips
Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 17 hours agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 10 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 2 weeks agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 10 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 10 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
Zacks via Yahoo Finance· 7 months agoRoche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales...
Ads
related to: herceptin, kadcyla